The EMED team has played a pivotal role in this legacy, designing and delivering specialized equipment for the production of key medical isotopes such as Cobalt-60 (Co-60), Molybdenum-99 (Mo-99), and more recently, Actinium-225 (Ac-225). These isotopes are essential for diagnostic imaging and targeted cancer therapies, and EMED’s contributions have helped ensure Canada remains at the forefront of isotope technology.
